ProCE Banner Activity

Slides: The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients with Advanced Pancreatic Cancer

Slideset Download
Download this concise slideset for expert insights into the use of PARP inhibitors as maintenance therapy for patients with advanced pancreatic cancer and specific molecular alterations.

Released: March 05, 2021

Expiration: March 04, 2022

No longer available for credit.

Share

Faculty

Paul E. Oberstein

Paul E. Oberstein, MD

Assistant Professor of Medicine
Division of Hematology/Medical Oncology
NYU Langone Health
Director, GI Medical Oncology
NYU Perlmutter Comprehensive Cancer Center
NYU Langone Healthy
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Ipsen Biopharmaceuticals Inc

Program Director Disclosure

Program Director

Paul E. Oberstein, MD

Assistant Professor of Medicine
Division of Hematology/Medical Oncology
NYU Langone Health
Director, GI Medical Oncology
NYU Perlmutter Comprehensive Cancer Center
NYU Langone Healthy
New York, New York